Adverse Events Following Immunization With Combined vs Concurrent Monovalent Hepatitis A and Typhoid Vaccines in Children

Abstract
Combined hepatitis A and typhoid vaccine is available in Australia, but licensed for use from age 16 years; however it is used “off-label” in children. The combined vaccine is well tolerated in children aged 2–16 years and the risk of adverse events is similar to those receiving concurrent monovalent vaccines.
Funding Information
  • Australian National Health and Medical Research Council Early Career fellowships (APP1109035, APP1158469)